Synata Bio
PrivateLast Round
Grant
Nov 19, 2024
Total Funding Raised
$324M
Company Overview
Synata Bio operates in Energy & Sustainability and is based in Warrenville, Illinois. Its latest recorded funding round was a Grant round in November 2024.
Synata Bio is an industrial chemicals company that develops fermentation technology to convert waste gases and synthesis gas into ethanol and other chemical products.
Sector
Energy & Sustainability
Verticals
Carbon Capture, Circular Economy, Biotechnology, Alternative Fuels, Clean Manufacturing
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Synata Bio Comparables
Compare Synata Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Jupeng Bio | 84% | |
| Phase Biolabs | 81% | |
| LanzaTech | 80% |
For institutional investors. Book with your work email.
Synata Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 19, 2024 | ||||
| Series D | Aug 22, 2011 | ||||
| Debt | Jan 20, 2011 | ||||
| Series C Extension | Apr 29, 2010 | ||||
| Series C | Dec 8, 2008 | ||||
Series B | Mar 21, 2008 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Synata Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GreatPoint Ventures | Series B, Series A, Series C |
| Blackstone | Series D, Series C |
| Khosla Ventures | Series B, Series C Extension, Series A, Series D, Series C |
| TotalEnergies Carbon Neutrality Ventures | Series D |
| National Development and Reform Commission | Grant |
| Advanced Technology Ventures | Series B, Series C Extension, Series A, Series C |
| Sumitomo Corporation | Series D, Series C |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 15, 2026
Monthly visitors increased 247% MoM, reaching 4.2K.
- May 2, 2025
Monthly visitors increased 68% MoM.
For institutional investors. Book with your work email.
Synata Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Synata Bio's valuation, stock price, and market status.
Is Synata Bio a public or private company?
Synata Bio is a private company.
What is the current stock price of Synata Bio?
Synata Bio is a private company, so its shares have no public market price. Caplight tracks Synata Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Synata Bio worth (valuation)?
Valuation information for Synata Bio is not publicly available.
Can I buy Synata Bio stock?
Synata Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Synata Bio's last funding round?
Synata Bio's most recent funding round was Grant on November 19, 2024.
Who are the main investors in Synata Bio?
Key investors in Synata Bio include Blackstone.
Will Synata Bio IPO soon?
No public IPO plans have been announced for Synata Bio.
How can I track Synata Bio secondary market activity?
Caplight tracks bids, offers, and trades in Synata Bio's shares on secondary markets.